{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:47:13Z","timestamp":1794620833251,"version":"4.9.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.lana.2025.101321","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:31:16Z","timestamp":1764991876000},"page":"101321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genomic landscape of hereditary cancer syndromes in the largest cohort in Colombia: a retrospective study"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-4853","authenticated-orcid":false,"given":"Juan Javier","family":"L\u00f3pez Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Hern\u00e1ndez-Bocanegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9122-678X","authenticated-orcid":false,"given":"Katherine","family":"Aguirre-Guataqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paula","family":"Rodr\u00edguez Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9901-4395","authenticated-orcid":false,"given":"Laura Camila","family":"Rios Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Cardenas-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Piza-Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-9913","authenticated-orcid":false,"given":"Paula","family":"Rueda-Gait\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-6055","authenticated-orcid":false,"given":"Julian","family":"Lamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Isaza-Ruget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lana.2025.101321_bib1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.annonc.2022.07.008","article-title":"Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers","volume":"33","author":"Jahn","year":"2022","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/genes14051025","article-title":"Hereditary cancer syndromes: a comprehensive review with a visual tool","volume":"14","author":"Garutti","year":"2023","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s12885-019-5756-4","article-title":"Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations","volume":"19","author":"Tsaousis","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lana.2025.101321_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mam.2019.03.001","article-title":"Update on genetic predisposition to colorectal cancer and polyposis","volume":"69","author":"Valle","year":"2019","journal-title":"Mol Aspects Med"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lana.2025.101321_bib6","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000003562","article-title":"Hereditary cancer syndromes and risk assessment: ACOG COMMITTEE OPINION, Number 793","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes\u2014association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lana.2025.101321_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5306\/wjco.v14.i2.40","article-title":"Hereditary cancer syndromes","volume":"14","author":"Imyanitov","year":"2023","journal-title":"World J Clin Oncol"},{"issue":"3","key":"10.1016\/j.lana.2025.101321_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.lana.2025.101321_bib10","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.3390\/cancers13143406","article-title":"The genetic analyses of French Canadians of Quebec facilitate the characterization of new cancer predisposing genes implicated in hereditary breast and\/or ovarian cancer syndrome families","volume":"13","author":"Fierheller","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9951","key":"10.1016\/j.lana.2025.101321_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The missing diversity in human genetic studies","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.lana.2025.101321_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1584178","article-title":"Cancer genomics and bioinformatics in Latin American countries: applications, challenges, and perspectives","volume":"15","author":"Torres-Narvaez","year":"2025","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40659-024-00579-x","article-title":"Regional hereditary cancer program in Chile: a scalable model of genetic counseling and molecular diagnosis to improve clinical outcomes for patients with hereditary cancer across Latin America","volume":"57","author":"Landeros","year":"2024","journal-title":"Biol Res"},{"issue":"7","key":"10.1016\/j.lana.2025.101321_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41431-025-01807-y","article-title":"Building a hereditary cancer program in Colombia: analysis of germline pathogenic and likely pathogenic variants spectrum in a high-risk cohort","volume":"33","author":"Sanabria-Salas","year":"2025","journal-title":"Eur J Hum Genet"},{"issue":"28","key":"10.1016\/j.lana.2025.101321_bib16","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1073\/pnas.1504447112","article-title":"Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations","volume":"112","author":"Kehdy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lana.2025.101321_bib17","article-title":"Germline genetic variants in cancer predisposition genes in patients from Latin America and the Caribbean","volume":"11","author":"Wegman-Ostrosky","year":"2025","journal-title":"JCO Glob Oncol"},{"issue":"8","key":"10.1016\/j.lana.2025.101321_bib18","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s12094-024-03415-6","article-title":"Genomic ancestry and cancer among Latin Americans","volume":"26","author":"Ru\u00edz-Pati\u00f1o","year":"2024","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"10.1016\/j.lana.2025.101321_bib19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1634\/theoncologist.2015-0416","article-title":"Founder and recurrent mutations in BRCA1 and BRCA2 genes in Latin American Countries: state of the art and literature review","volume":"21","author":"Ossa","year":"2016","journal-title":"Oncologist"},{"issue":"43","key":"10.1016\/j.lana.2025.101321_bib20","doi-asserted-by":"crossref","first-page":"74233","DOI":"10.18632\/oncotarget.18815","article-title":"BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile","volume":"8","author":"Alvarez","year":"2017","journal-title":"Oncotarget"},{"issue":"9596","key":"10.1016\/j.lana.2025.101321_bib21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lana.2025.101321_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41436-019-0633-8","article-title":"A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients","volume":"22","author":"LaDuca","year":"2020","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13073-022-01101-2","article-title":"Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients","volume":"14","author":"Ceyhan-Birsoy","year":"2022","journal-title":"Genome Med"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib25","doi-asserted-by":"crossref","first-page":"a004739","DOI":"10.1101\/mcs.a004739","article-title":"A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen)","volume":"5","author":"Ritter","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"9","key":"10.1016\/j.lana.2025.101321_bib28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations between cancer predisposition testing panel genes and breast cancer","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.lana.2025.101321_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ejhg.2008.212","article-title":"Breast cancer susceptibility: current knowledge and implications for genetic counselling","volume":"17","author":"Ripperger","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.lana.2025.101321_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.anorl.2019.09.002","article-title":"French scientific medical journals confronted by developments in medical writing and the transformation of the medical press","volume":"136","author":"Laccourreye","year":"2019","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13073-022-01101-2","article-title":"Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients","volume":"14","author":"Ceyhan-Birsoy","year":"2022","journal-title":"Genome Med"},{"issue":"8","key":"10.1016\/j.lana.2025.101321_bib32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41431-023-01380-2","article-title":"Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients","volume":"31","author":"Henkel","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"23","key":"10.1016\/j.lana.2025.101321_bib33","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.lana.2025.101321_bib34","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMp1908940","article-title":"Kicking the can Down the road\u2014when medical schools fail to self-regulate","volume":"381","author":"Santen","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lana.2025.101321_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ajhg.2009.08.018","article-title":"Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer","volume":"85","author":"Tavtigian","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.lana.2025.101321_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1535-7163.MCT-11-0581","article-title":"Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma","volume":"11","author":"Kim","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-006-9435-1","article-title":"Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)","volume":"105","author":"Specht","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/heapol\/czs138","article-title":"Paying health workers for performance in a fragmented, fragile state: reflections from Katanga Province, Democratic Republic of Congo","volume":"29","author":"Fox","year":"2014","journal-title":"Health Pol Plan"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib39","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.01.022","article-title":"Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer","volume":"146","author":"Win","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib40","article-title":"Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers","volume":"11","author":"Choi","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/genes14051077","article-title":"Hereditary gastric cancer: single-gene or multigene panel testing? A mono-institutional experience","volume":"14","author":"Calvello","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.lana.2025.101321_bib42","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2017.35.15_suppl.1581","article-title":"Germline mutations in cancer predisposition genes among patients with thyroid cancer","volume":"35","author":"Kamihara","year":"2017","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.lana.2025.101321_bib43","article-title":"Comprehensive germline panel testing across cancer types: diagnostic yield and clinical utility in 100,000 patient dataset","volume":"37","author":"Yang","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.lana.2025.101321_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/bioinformatics\/bts144","article-title":"Fast and accurate inference of local ancestry in Latino populations","volume":"28","author":"Baran","year":"2012","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.lana.2025.101321_bib45","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00018-014-1791-0","article-title":"MITF in melanoma: mechanisms behind its expression and activity","volume":"72","author":"Hartman","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib46","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1038\/s41598-017-05056-y","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 germline mutations in Colombian breast cancer patients","volume":"7","author":"Torres","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7705\/biomedica.4673","article-title":"C\u00e1ncer de mama en seis familias del Tolima y el Huila: mutaci\u00f3n BRCA1 3450del4 [Breast cancer in six families from Tolima and Huila: BRCA1 3450del4 mutation]","volume":"40","author":"Benavides","year":"2020","journal-title":"Biomedica"},{"issue":"10","key":"10.1016\/j.lana.2025.101321_bib48","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/bioinformatics\/bts144","article-title":"Fast and accurate inference of local ancestry in Latino populations","volume":"28","author":"Baran","year":"2012","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.lana.2025.101321_bib49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/jid.2014.319","article-title":"Pro-survival role of MITF in melanoma","volume":"135","author":"Hartman","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74237-z","article-title":"Cancer risks associated with the germline MITF(E318K) variant","volume":"10","author":"Guhan","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.lana.2025.101321_bib51","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.3390\/cancers13122920","article-title":"MITF promotes cell growth, migration and invasion in clear cell renal cell carcinoma by activating the RhoA\/YAP signal pathway","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.lana.2025.101321_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s12276-024-01175-5","article-title":"Emerging roles of MITF as a crucial regulator of immunity","volume":"56","author":"Lee","year":"2024","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13053-021-00189-8","article-title":"Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature","volume":"19","author":"Oliveira","year":"2021","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.lana.2025.101321_bib54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/1471-2407-10-389","article-title":"Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients","volume":"10","author":"Fostira","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lana.2025.101321_bib55","article-title":"Recurrent germline mutations of CHEK2 as a new susceptibility gene in patients with pheochromocytomas and paragangliomas","volume":"2021","author":"Gao","year":"2021","journal-title":"Internet J Endocrinol"},{"issue":"8","key":"10.1016\/j.lana.2025.101321_bib56","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s10038-018-0466-3","article-title":"Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients","volume":"63","author":"Apostolou","year":"2018","journal-title":"J Hum Genet"},{"key":"10.1016\/j.lana.2025.101321_bib65","author":"Caffrey"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/gim.2013.166","article-title":"ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis)","volume":"16","author":"Hegde","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.lana.2025.101321_bib57","article-title":"Cost-effectiveness of next-generation sequencing versus single-gene testing for the molecular diagnosis of patients with metastatic non-small-cell lung cancer from the perspective of Spanish reference centers","volume":"7","author":"Arriola","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"9","key":"10.1016\/j.lana.2025.101321_bib58","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jval.2024.04.023","article-title":"Assessing the cost-effectiveness of next-generation sequencing as a biomarker testing approach in oncology and policy implications: a literature review","volume":"27","author":"Mirza","year":"2024","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.lana.2025.101321_bib59","article-title":"The cost-effectiveness of multigene panel testing for hereditary breast and ovarian cancer in Norway","volume":"4","author":"Asphaug","year":"2019","journal-title":"MDM Policy Pract"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10897-018-0226-8","article-title":"Reduction of health care costs and improved appropriateness of incoming test orders: the impact of genetic counselor review in an academic genetic testing laboratory","volume":"27","author":"Wakefield","year":"2018","journal-title":"J Genet Counsel"},{"issue":"3","key":"10.1016\/j.lana.2025.101321_bib61","first-page":"328","article-title":"An electronic strategy for eliminating unnecessary duplicate genetic testing","volume":"153","author":"Riley","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.lana.2025.101321_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40271-020-00412-z","article-title":"The economic impact on Australian patients with neuroendocrine tumours","volume":"13","author":"Gordon","year":"2020","journal-title":"Patient"},{"issue":"5","key":"10.1016\/j.lana.2025.101321_bib63","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25003321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25003321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:18:36Z","timestamp":1776208716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X25003321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S2667193X25003321"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2025.101321","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic landscape of hereditary cancer syndromes in the largest cohort in Colombia: a retrospective study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2025.101321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101321"}}